Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 24, 2026

Newmont expects Cadia to return to 80% capacity in 5 weeks and maintains 2026 guidance with new $6B buyback authorization

View original at seekingalpha.com
“"In the first quarter, we produced 1.3 million ounces of gold, 30,000 tonnes of copper and 9 million ounces of silver" and "$3.8 billion in cash flow from operations after working capital and $3.1 billion in free cash flow, marking another all-time quarterly record." (CEO, President & Director Viljoen)”
Verbatim excerpt from the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Q1 2026 free cash flow of $3.1 billion was a record even after approximately $1.3 billion in cash tax payments.

    60% confidence
  • Newmont's acquisition appetite is minimal; focus remains firmly internal on its own operations.

    60% confidence
  • Newmont produced 1.3 million ounces of gold, 30,000 tonnes of copper, and 9 million ounces of silver in Q1 2026, generating $3.8 billion in operating cash flow and a record $3.1 billion in free cash flow.

    60% confidence
  • The Nevada Gold Mines notice of default period is open-ended with no set timeline for resolution, but Newmont hopes to resolve it in the near term through the structured JV agreement process.

    60% confidence
  • Newmont repurchased $2.4 billion in shares since the last earnings call, bringing total repurchases to $6 billion over 24 months.

    60% confidence
  • Newmont received approximately $321 million in after-tax proceeds from sale of SolGold and Greatland Resources equity, bringing total noncore divestiture proceeds to over $4.6 billion.

    60% confidence
  • Q2 will be a slightly lower production quarter as expected, with Q3 expected to come back stronger.

    60% confidence
  • Newmont declared a dividend of $0.26 per share in Q1 2026, spent $381 million in sustaining capital, and deployed $239 million in development capital.

    60% confidence
  • Q2 2026 production is expected slightly below Q1, keeping Newmont on track for full year guidance of 5.3 million ounces.

    60% confidence
  • Newmont is in active, commercially and technically disciplined engagement in response to the Ghana contractor mining directive.

    60% confidence
  • The CFO recruitment process is progressing well and Newmont expects to share more information soon.

    60% confidence
  • Q1 outperformance provides prudent flexibility to absorb any impact from temporary mill feed interruptions at Cadia in Q2.

    60% confidence
  • Newmont delivered adjusted EBITDA of $5.2 billion, adjusted net income of $2.90 per diluted share, and gold all-in sustaining costs of $1,029 per ounce (byproduct basis) in Q1 2026.

    60% confidence
  • Remedies under the Nevada Gold Mines JV default include a range of possibilities being worked through the structured JV agreement process.

    60% confidence
  • All-in sustaining costs are expected to be notably higher in Q2 2026, more in line with guidance provided in February.

    60% confidence
  • Newmont's Q1 results demonstrate it is on track to achieve 2026 guidance, reflecting consistent and predictable operational performance.

    60% confidence
  • Newmont's inflation management levers are productivity and cost discipline, supported by a strong supply chain team.

    60% confidence
  • Ghana's new sliding scale royalty creates an incremental cost headwind of approximately $25 per ounce for Newmont in 2026, to be mitigated through cost management and productivity.

    60% confidence
  • As of Q4 2025 Newmont had limited information on Nevada Gold Mines; by Q1 2026 the company has moved to exercising audit rights and reviewing findings, indicating a more engaged posture.

    60% confidence
  • Record free cash flow generation is flowing through the enhanced capital allocation framework, enabling reinvestment, dividends, and a new $6 billion share repurchase authorization.

    60% confidence
  • 2026 is a trough year for Newmont; the company will consider 2027 guidance as it works through the year.

    60% confidence
  • Cadia underground rehabilitation is expected to be completed in the next 5 weeks, enabling return to 80% operating capacity, with full recovery expected by end of Q2 2026.

    60% confidence
  • Newmont is maintaining its full year cost guidance while monitoring the geopolitical environment and its potential impact on costs.

    60% confidence
  • Notable energy price increases and global supply chain disruptions are being actively mitigated using Newmont's scale and supply chain team.

    60% confidence

Data points we hold from this source

Newmont Corporation · gold production1.3 million_oz
Newmont Corporation · buyback authorization new6 USD
Newmont Corporation · cumulative divestiture proceeds4.6 USD
Newmont Corporation · sustaining capital expenditure381 USD
Newmont Corporation · eps2.90 USD
Newmont Corporation · gold aisc byproduct1029 USD_per_oz
Newmont Corporation · ghana royalty cost headwind25 USD_per_oz
Newmont Corporation · share buybacks since last call2.4 USD
Newmont Corporation · dividend per share0.26 USD
Newmont Corporation · silver production9 million_oz
Newmont Corporation · cash flow from operations3.8 USD
Newmont Corporation · copper production30000 tonnes
Newmont Corporation · cash tax payments1.3 USD
Newmont Corporation · cumulative share buybacks6 USD
Newmont Corporation · divestiture proceeds q1321 USD
Newmont Corporation · development capital expenditure239 USD
Newmont Corporation · gold production guidance fy5.3 million_oz
Newmont Corporation · adjusted ebitda5.2 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com
Newmont expects Cadia to return to 80% capacity in 5 weeks and maintains 2026 guidance with new $6B buyback authorization — Source | Via News | ViaNews Market